Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Children's Oncology Group
Children's Oncology Group
Nationwide Children's Hospital
Children's Oncology Group
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Memorial Sloan Kettering Cancer Center
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Children's Oncology Group
National Cancer Institute (NCI)
Lund University Hospital
Columbia University
University of Texas Southwestern Medical Center
Samsung Medical Center
University Hospital, Bonn
Children's Oncology Group
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
NYU Langone Health
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Universitätsklinikum Hamburg-Eppendorf
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Seoul National University Hospital
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
NYU Langone Health
Gustave Roussy, Cancer Campus, Grand Paris